 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Collagen-binding
|
PDB id
|
|
|
|
1ao3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
272:25162-25167
(1997)
|
|
PubMed id:
|
|
|
|
|
| |
|
The von willebrand factor A3 domain does not contain a metal ion-dependent adhesion site motif.
|
|
J.Bienkowska,
M.Cruz,
A.Atiemo,
R.Handin,
R.Liddington.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
von Willebrand factor (vWF) is a multimeric plasma protein that mediates
platelet adhesion to exposed subendothelium at sites of vascular injury. The A3
domain of vWF (vWF-A3) forms the principal binding site for collagens type I and
III. We report here the crystal structure of the vWF-A3 domain at 2.2-A
resolution. As expected, the structure is similar to the integrin I domain but
with several novel features. Sequence alignments had suggested that the domain
contained an integrin metal ion-dependent adhesion site (MIDAS) motif, but the
crystal structure shows that the motif is modified and that no metal ion is
bound. We have introduced mutations into the vestigial MIDAS motif and report
that, unlike the I domain of integrin alpha2beta1, vWF-A3 continues to bind
collagen after disruption of the motif. We conclude that collagen recognition by
vWF-A3 occurs by a mechanism different from that of the integrin alpha2beta1.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Fig. 3. Stereo diagram of the vWF-A3 vestigial MIDAS motif,
with schematic main chain and ball-and-stick side chains. The
water molecule is labeled W, with hydrogen bonds as dashed red
lines. Drawn with MOLSCRIPT (25), RASTER3D (26), and RENDER (27).
|
 |
Figure 4.
Fig. 4. The effect of mutations in the vestigial MIDAS motif
on collagen binding. Percentage of normal binding to
immobilized^ type I collagen detected by enzyme-linked
immunosorbent assay.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(1997,
272,
25162-25167)
copyright 1997.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.P.Hendrickx,
J.M.Budzik,
S.Y.Oh,
and
O.Schneewind
(2011).
Architects at the bacterial surface - sortases and the assembly of pili with isopeptide bonds.
|
| |
Nat Rev Microbiol, 9,
166-176.
|
 |
|
|
|
|
 |
A.R.Klatt,
A.K.Becker,
C.D.Neacsu,
M.Paulsson,
and
R.Wagener
(2011).
The matrilins: modulators of extracellular matrix assembly.
|
| |
Int J Biochem Cell Biol, 43,
320-330.
|
 |
|
|
|
|
 |
M.Nakajima,
Y.Miyamoto,
and
S.Ikegawa
(2011).
Cloning and characterization of the osteoarthritis-associated gene DVWA.
|
| |
J Bone Miner Metab, 29,
300-308.
|
 |
|
|
|
|
 |
J.Emsley
(2010).
Convergent recognition of a triple helical hydrophobic motif in collagen.
|
| |
Structure, 18,
1-2.
|
 |
|
|
|
|
 |
T.Izoré,
C.Contreras-Martel,
L.El Mortaji,
C.Manzano,
R.Terrasse,
T.Vernet,
A.M.Di Guilmi,
and
A.Dessen
(2010).
Structural basis of host cell recognition by the pilus adhesin from Streptococcus pneumoniae.
|
| |
Structure, 18,
106-115.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.F.De Meyer,
H.Deckmyn,
and
K.Vanhoorelbeke
(2009).
von Willebrand factor to the rescue.
|
| |
Blood, 113,
5049-5057.
|
 |
|
|
|
|
 |
E.Hohenester,
T.Sasaki,
C.Giudici,
R.W.Farndale,
and
H.P.Bächinger
(2008).
Structural basis of sequence-specific collagen recognition by SPARC.
|
| |
Proc Natl Acad Sci U S A, 105,
18273-18277.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.S.Seo,
C.Q.Zeng,
J.M.Hyser,
B.Utama,
S.E.Crawford,
K.J.Kim,
M.Höök,
and
M.K.Estes
(2008).
Inaugural article: integrins alpha1beta1 and alpha2beta1 are receptors for the rotavirus enterotoxin.
|
| |
Proc Natl Acad Sci U S A, 105,
8811-8818.
|
 |
|
|
|
|
 |
C.Martin,
L.D.Morales,
and
M.A.Cruz
(2007).
Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha.
|
| |
J Thromb Haemost, 5,
1363-1370.
|
 |
|
|
|
|
 |
L.Shapiro,
J.Love,
and
D.R.Colman
(2007).
Adhesion molecules in the nervous system: structural insights into function and diversity.
|
| |
Annu Rev Neurosci, 30,
451-474.
|
 |
|
|
|
|
 |
L.D.Morales,
C.Martin,
and
M.A.Cruz
(2006).
The interaction of von Willebrand factor-A1 domain with collagen: mutation G1324S (type 2M von Willebrand disease) impairs the conformational change in A1 domain induced by collagen.
|
| |
J Thromb Haemost, 4,
417-425.
|
 |
|
|
|
|
 |
T.A.Springer
(2006).
Complement and the multifaceted functions of VWA and integrin I domains.
|
| |
Structure, 14,
1611-1616.
|
 |
|
|
|
|
 |
J.F.Dong
(2005).
Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions.
|
| |
J Thromb Haemost, 3,
1710-1716.
|
 |
|
|
|
|
 |
A.A.Bhattacharya,
M.L.Lupher,
D.E.Staunton,
and
R.C.Liddington
(2004).
Crystal structure of the A domain from complement factor B reveals an integrin-like open conformation.
|
| |
Structure, 12,
371-378.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.Nishida,
H.Sumikawa,
M.Sakakura,
N.Shimba,
H.Takahashi,
H.Terasawa,
E.Suzuki,
and
I.Shimada
(2003).
Collagen-binding mode of vWF-A3 domain determined by a transferred cross-saturation experiment.
|
| |
Nat Struct Biol, 10,
53-58.
|
 |
|
|
|
|
 |
R.I.Handin
(2003).
A hitchhiker's guide to the galaxy--an H. pylori travel guide.
|
| |
Gastroenterology, 124,
1983-1985.
|
 |
|
|
|
|
 |
Z.M.Ruggeri
(2003).
Von Willebrand factor, platelets and endothelial cell interactions.
|
| |
J Thromb Haemost, 1,
1335-1342.
|
 |
|
|
|
|
 |
B.Savage,
J.J.Sixma,
and
Z.M.Ruggeri
(2002).
Functional self-association of von Willebrand factor during platelet adhesion under flow.
|
| |
Proc Natl Acad Sci U S A, 99,
425-430.
|
 |
|
|
|
|
 |
C.A.Whittaker,
and
R.O.Hynes
(2002).
Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere.
|
| |
Mol Biol Cell, 13,
3369-3387.
|
 |
|
|
|
|
 |
D.E.Gullberg,
and
E.Lundgren-Akerlund
(2002).
Collagen-binding I domain integrins--what do they do?
|
| |
Prog Histochem Cytochem, 37,
3.
|
 |
|
|
|
|
 |
J.E.Garbarino,
and
I.R.Gibbons
(2002).
Expression and genomic analysis of midasin, a novel and highly conserved AAA protein distantly related to dynein.
|
| |
BMC Genomics, 3,
18.
|
 |
|
|
|
|
 |
E.G.Huizinga,
A.Schouten,
T.M.Connolly,
J.Kroon,
J.J.Sixma,
and
P.Gros
(2001).
The structure of leech anti-platelet protein, an inhibitor of haemostasis.
|
| |
Acta Crystallogr D Biol Crystallogr, 57,
1071-1078.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.R.Huth,
E.T.Olejniczak,
R.Mendoza,
H.Liang,
E.A.Harris,
M.L.Lupher,
A.E.Wilson,
S.W.Fesik,
and
D.E.Staunton
(2000).
NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding.
|
| |
Proc Natl Acad Sci U S A, 97,
5231-5236.
|
 |
|
|
|
|
 |
Z.Li
(1999).
The alphaMbeta2 integrin and its role in neutrophil function.
|
| |
Cell Res, 9,
171-178.
|
 |
|
|
|
|
 |
E.T.Baldwin,
R.W.Sarver,
G.L.Bryant,
K.A.Curry,
M.B.Fairbanks,
B.C.Finzel,
R.L.Garlick,
R.L.Heinrikson,
N.C.Horton,
L.L.Kelley,
A.M.Mildner,
J.B.Moon,
J.E.Mott,
V.T.Mutchler,
C.S.Tomich,
K.D.Watenpaugh,
and
V.H.Wiley
(1998).
Cation binding to the integrin CD11b I domain and activation model assessment.
|
| |
Structure, 6,
923-935.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.E.Sadler
(1998).
Biochemistry and genetics of von Willebrand factor.
|
| |
Annu Rev Biochem, 67,
395-424.
|
 |
|
|
|
|
 |
R.Celikel,
K.I.Varughese,
Madhusudan,
A.Yoshioka,
J.Ware,
Z.M.Ruggeri,
R.Celikel,
K.I.Varughese,
Madhusudan,
A.Yoshioka,
J.Ware,
and
Z.M.Ruggeri
(1998).
Crystal structure of the von Willebrand factor A1 domain in complex with the function blocking NMC-4 Fab.
|
| |
Nat Struct Biol, 5,
189-194.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Sasaki,
E.Hohenester,
W.Göhring,
and
R.Timpl
(1998).
Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin.
|
| |
EMBO J, 17,
1625-1634.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|